Hepatitis B vaccine urged for all infants, adolescents

Article Abstract:

Articles in the October 18, 1995 issue of the Journal of the American Medical Assn indicate that all infants should receive vaccination against hepatitis B; for those who were not innoculated as babies, vaccination in adolescence is also medically and economically viable. In addition, perinatal transmissions can be reduced by half by treating babies whose mothers have tested positive for a hepatitis B antigen, saving $41.8 million in medical and work-lost costs. Infant innoculation would save an additional $19.7 million, while adolescent immunization would save $3.5 million.

Pharmaceutical Preparation Manufacturing, Biological products exc. diagnostic, Vaccines for Human Use, Usage, Vaccines, Hepatitis B, Hepatitis B vaccine, Hepatitis B vaccines

---

Confronting medicine's glass ceiling

Article Abstract:

Female physicians continue to face education and job discrimination. For example, they earn one-third less than their male counterparts and comprise just 3% of medical school department heads. In addition, few medical researchers are women. The American Medical Society has adopted ten points to eliminate discrimination; for example, it suggests that immediate action be taken to increase the number of women in leadership roles in medical schools. In addition, blind peer review should be instituted for research fund applications and at journals.

Social aspects, Editorial, Women physicians, Sex discrimination against women, American Medical Association. Council on Ethical and Judicial Affairs

---

Researchers ask FDA to regulate tobacco as a drug

Article Abstract:

Antitobacco physicians hope that new studies published in the British Medical Assn journal Tobacco Control will convince the FDA to declare tobacco a drug. The studies' authors contend that smokeless tobacco makers deliberately alter the product's chemical content and take other steps to encourage users to become addicted. By naming tobacco a drug, the FDA could regulate nicotine levels.

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Other Tobacco Product Manufacturing, Product Safety-Drugs & Cosmetics, Moist Smokeless Tobacco, Chewing and smoking tobacco, Research, Laws, regulations and rules, Drugs, Product safety, Tobacco industry, United States. Food and Drug Administration, Smokeless tobacco, Chewing tobacco

Similar abstracts:

• Abstracts: Coalition backs bill to let FDA regulate tobacco. Smoking control advocates split over focus on youth. Groups charge Clinton advisor has ties to tobacco industry
• Abstracts: Putting doctor data on Internet. Detailers back on doctor's doorstep. Honoring a vanishing breed - the country doctor
• Abstracts: Hormone replacement therapy and risk of breast cancer: results of epidemiologic studies. Post-menopausal hormone use and tooth loss: a prospective study
• Abstracts: Gestational diabetes alters human placental vascular responses to changes in oxygen tension. A comparison opf rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity and preterm delivery
• Abstracts: A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. Meningococcal disease in Los Angeles County, California, and among men in the county jails

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.